Brief: Gland Pharma Says Received Tentative Approval From US FDA For Angiotensin II Injection

Gland Pharma

15/11/2023 07:32

Nov 15 (Reuters) - Gland Pharma Ltd  GLAD.NS :
    * RECEIVES TENTATIVE APPROVAL FROM US FDA FOR ANGIOTENSIN II
INJECTION
    * WILL LAUNCH PRODUCT WITH ITS MARKETING PARTNER ON RECEIPT
OF
FINAL APPROVAL
    * MAY BE ELIGIBLE FOR 180 DAYS OF GENERIC DRUG EXCLUSIVITY

Source text for Eikon:  ID:nBSE48S09L 
Further company coverage:  GLAD.NS 

 ((reuters.briefs@thomsonreuters.com;))